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Background and Purpose—Value-based health care aims to bring together patients and health systems to maximize the 
ratio of quality over cost. To enable assessment of healthcare value in stroke management, an international standard set of 
patient-centered stroke outcome measures was defined for use in a variety of healthcare settings.
Methods—A modified Delphi process was implemented with an international expert panel representing patients, advocates, 
and clinical specialists in stroke outcomes, stroke registers, global health, epidemiology, and rehabilitation to reach 
consensus on the preferred outcome measures, included populations, and baseline risk adjustment variables.
Results—Patients presenting to a hospital with ischemic stroke or intracerebral hemorrhage were selected as the target 
population for these recommendations, with the inclusion of transient ischemic attacks optional. Outcome categories 
recommended for assessment were survival and disease control, acute complications, and patient-reported outcomes. 
Patient-reported outcomes proposed for assessment at 90 days were pain, mood, feeding, selfcare, mobility, 
communication, cognitive functioning, social participation, ability to return to usual activities, and health-related 
quality of life, with mobility, feeding, selfcare, and communication also collected at discharge. One instrument was 
able to collect most patient-reported subdomains (9/16, 56%). Minimum data collection for risk adjustment included 
patient demographics, premorbid functioning, stroke type and severity, vascular and systemic risk factors, and specific 
treatment/care-related factors.
Conclusions—A consensus stroke measure Standard Set was developed as a simple, pragmatic method to increase the value 
of stroke care. The set should be validated in practice when used for monitoring and comparisons across different care 
settings.   (Stroke. 2016;47:180-186. DOI: 10.1161/STROKEAHA.115.010898.)
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The global stroke epidemic continues to increase, with a disproportionate burden present and increasing among 
low-income countries.1 There is an urgent need for better 
strategies to deliver efficient and effective care, while reduc-
ing disparities between countries, because of the societal 
burden posed by stroke. A proposed strategy for improving 
quality of care involves measuring the value-based health care 
given to patients.2 In this framework, value is defined as the 
total benefit gained by a patient relative to the cost of obtain-
ing that benefit (ie, health outcomes divided by the cost to 
achieve those outcomes).3 Defining condition-specific mea-
surable outcomes that are meaningful to patients is critical to 
this equation. Outcomes can be broken into the broad catego-
ries of survival, disease control, complications of treatment, 
and long-term quality of life. The importance of each can vary 
from patient to patient.4 Despite existing efforts in the area 
of patient-reported outcome measures (PROMs) to quantify 
stroke outcomes accurately using validated instruments, there 
is significant variability across instruments and domains, 
and no agreement about which critical measures should 
be routinely captured.5–8 To define a set of global standards 
for measuring outcomes that matter most to stroke patients, 
an international expert panel was assembled representing 
patients, advocates, and clinician experts in stroke outcomes, 
registers, global health, epidemiology, and rehabilitation.
Methods
Assembling the Expert Panel
The primary aim of this expert consensus group was to define the 
Stroke Standard Set, a minimum set of outcomes and risk adjust-
ment variables that are highest priority to collect for all patients 
hospitalized with stroke and designed to be able to be measured in 
any country within an existing register or as a free-standing set. The 
working group was created and coordinated by the International 
Consortium for Health Outcomes Measurement (ICHOM, http://
www.ICHOM.org), a nonprofit organization focused on the devel-
opment of standard sets of outcomes and related risk factors for 
individual medical conditions. An executive leadership team was 
composed of a volunteer senior stroke outcomes expert (L.H.S.), 
a salaried ICHOM project manager (S.S.), and a neurology trainee 
ICHOM research fellow (J.S.). The executive team identified and 
invited international expert members to participate with the aim 
of establishing a geographically diverse group covering a broad 
range of stroke specialties. Members represented stroke patients, 
specialties from all phases of stroke care, and major international 
professional societies, stroke registers, and centers (Table I in the 
online-only Data Supplement).
Process
The working group defined the Stroke Standard Set by executing a 
structured consensus-driven modified Delphi method by the way of 
frequent iterative teleconferences, videoconferences, and online sur-
veys to develop proposals based on evidence and expert opinion.9 The 
group convened 6 times from June 2014 to January 2015. Each tele-
conference or videoconference was followed by formal web surveys 
to gather feedback and make decisions on the proposals discussed 
during the conference calls. In decision-making, the group used a 
two-thirds majority vote for determining which variables or measures 
should be included in the Standard Set. All voting results were re-
viewed with the group at each call, and there was unanimous agree-
ment on the final selected set, detailed data elements, and abstraction 
instructions provided.
Core Principles
In reviewing candidate measures, the panel’s decision to include or 
exclude elements from the Standard Set was governed by a set of 
guiding principles, which were unanimously adopted by the panel 
at the onset of the process. These included emphasizing or prioritiz-
ing (1) pragmatism over idealism; (2) completeness in data collec-
tion over breadth of areas surveyed; (3) measures that can also be 
collected through retrospective abstraction; (4) instruments that are 
perpetually freely available and ideally with a digital platform; (5) 
instruments made of modular subunits that permit recombination of 
elements; and (6) measures robust to comparison in both low- and 
high-income countries and with available cost utility values to calcu-
late measures of cost-effectiveness.
Results
Condition Scope
The Standard Set was developed for evaluation of adult 
patients (age ≥18 years) presenting to a hospital with isch-
emic stroke (IS) or intracerebral hemorrhage (ICH). This 
scope of IS and ICH covers >90% of the global burden of 
incident stroke with high diagnostic reliability based on epide-
miological studies performed worldwide at varied proportions 
between countries.10,11 Inclusion of both IS and ICH is needed 
to create a global model for stroke and allows a greater focus 
on uniformly capturing stroke severity (an essential predictor 
of outcome).
Subarachnoid hemorrhage (SAH) was excluded from case 
entry because of the substantially different course of treatment 
and outcomes in patients with SAH. Although SAH is more 
likely to be distinguished from IS or ICH based on clinical pre-
sentation and age, differentiating between ISH and ICH in set-
tings where imaging technologies are not available would require 
inferential (rather than definite) classification based on proxy 
variables. Given heterogeneity in SAH case ascertainment, as 
well as the markedly different nature of SAH management, and 
impact on outcomes, not including SAH in the initial Standard 
Set was favored. Future working groups will define outcomes 
and relevant risk factors for SAH and childhood stroke.
Inclusion of transient ischemic attack (TIA) or of patients 
with IS or ICH, who are evaluated but not hospitalized, is rec-
ommended to be optional. The recommendation for optional 
inclusion of TIA or nonhospitalized patients reflects a sug-
gested balance between avoiding the exclusion of an impor-
tant patient group and maximizing accuracy and reliability of 
data collection, given the challenges of variation in imaging 
and pathogenic workup that produces low inter-rater reliabil-
ity in TIA case ascertainment most pronounced in resource 
limited settings. In lieu of this recommendation, the Standard 
Set includes a report of symptom duration to probabilistically 
assist in distinguishing case subtypes.
Treatments
The treatment approaches collected in the Standard Set are 
restricted to thrombolysis, endovascular thrombectomy, and 
hemicraniectomy, the only procedures for which evidence 
convincingly shows a large impact on mortality and disability. 
Given the wide variation in definition and function of stroke 
units worldwide, admission to a stroke unit is not collected 
in the Standard Set. It is expected and encouraged that many 
sites will continue to collect existing additional process and 
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performance measures, but this minimum data set was con-
structed to be pragmatic and feasible worldwide.
Outcome Domains and Measures
The full Delphi voting results of the outcome domains were 
collected and shared with all group members (Table II in the 
online-only Data Supplement).
Survival and Disease Control
We selected overall survival and recurrence of disease as 
core measures of treatment effectiveness and disease pre-
vention for the Standard Set. Effectiveness of smoking ces-
sation was also selected given the attributable risk of future 
vascular events associated with smoking and its dispropor-
tionate impact in low-income countries. Survival is mea-
sured as all-cause mortality, calculated from clinical and 
administrative data sources, and collected at 7 days from 
index hospital admission for stroke or at discharge, which-
ever is first, and then again at 90 to 120 days and 1 year 
after admission for the index event (Figure). The group rec-
ommended tracking survival annually ≤5 years largely via 
administrative data sources. All-cause mortality is preferred 
over cardiovascular mortality because of poor reliability in 
the classification of cause of death. It is acknowledged that 
it may be challenging to collect this information (eg, 19% of 
countries do not have a system in place for reporting cause-
specific mortality)12; however, it is key to understanding the 
long-term outcomes of stroke patients whose care usually 
transitions back to general primary care after the first year 
post stroke.13
Recurrence of disease (stroke and TIA) is defined as a 
self or proxy report of new stroke symptoms assessed at 90 
days. Although some health systems are capable of accurately 
tracking new diagnoses of stroke, there is still variability in 
the accessibility of clinical data and the reliability of diagno-
ses. Thus, there may be a higher degree of consistency and 
reliability through a standardized self or proxy report of recur-
rent stroke or TIA.
Acute Complications
Because the treatments for stroke and their sequelae are het-
erogeneous and exert their effects via long-term disability 
measurable through patient-reported functional outcomes, 
the group narrowed the focus of measuring treatment-related 
complications to symptomatic ICH after thrombolysis. This 
information would be abstracted from clinical data at dis-
charge or at 7 days after index hospital admission. Data on 
complications after other treatments, such as carotid surgery, 
are not included in the Standard Set.
Patient-Reported Health Status
Stroke survivors may have symptoms that are not typically 
captured by more conventional PROMs or clinician-reported 
outcomes. Therefore, individual subdomains of fatigue, 
depression, and anxiety were collected rather than a single 
composite domain. This resulted in elements and subdomains 
for cognitive and psychiatric functioning, motor functioning, 
nonmotor functioning, social functioning, general health sta-
tus, and health-related quality of life (Table).
Data on mobility, feeding, toileting, dressing, and ability to 
communicate serve as a minimum data set at discharge because 
of its practical availability from clinical data or provider report-
ing, and its wide applicability across different regions in the 
world where the use of postacute care facilities (eg, rehabilita-
tion, chronic nursing care, or home care) is highly variable. 
The full assessment of all PROMs occurs as part of a single 
focused assessment at 90 to 120 days after index admission.
PROMs have gradually been integrated with more tradi-
tional process-oriented metrics of stroke care.14,15 To find the 
optimal balance between precision and pragmatism, the group 
sought to select a single well-validated instrument that would 
be able to address the multidimensional outcome domains 
in stroke with minimal floor or ceiling effects common to 
many instruments, while maximizing the likelihood of reli-
able longitudinal data collection. Many options and their vari-
ous permutations were considered including promising tools 
still in development, such as Neuro-QOL.16 In the interest of 
Recommended
T0 Discharge* 90 days after 
admission for 
index event**
5 years post 
stroke
3 years post 
stroke
2 years post 
stroke
1 year post 
stroke
4 years post 
stroke
Entrance into outcome tracking system for stroke
Baseline characteristics / Risk adjustment variables
PROMs (patient reported outcome measures) – brief discharge assessment
PROMs (patient reported outcome measures) – full assessment
Clinician reported – Symptomatic intracranial hemorrhage after ischemic stroke
Survival
* Discharge or 7 days after admission for index event (whichever occurs first).
** 90 days after admission for index event within a 30-day window (i.e., 90 to 120 days after index admission).
T0
Figure. Timeline of data collection.
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identifying a standardized tool that can be used at any center 
in any country, a core PROMs instrument was recommended: 
the Patient Reported Outcomes Measurement Information 
System 10-Question Short Form (PROMIS SF v1.1 Global 
Health, equivalent to the PROMIS global items and domain 
item banks).17,18 The PROMIS-10 is available through the 
National Institutes of Health (NIH) Assessment Center as 
analog (printed paper algorithms) or a digital platform (web-
enabled or offline). There are no associated fees for its use, 
and it is available in multiple languages. The PROMIS-10 
scores can be converted to other scores of established instru-
ments for comparison: the Short Form 36-Question Health 
Survey, modified Rankin Scale (mRS), Barthel Index, and the 
widely used EuroQOL-5 Dimension Questionnaire that also 
allows for calculation of quality-adjusted life-years.17,19–21
The PROMIS-10 covers the majority of the outcome 
domains considered most important by the expert panel. 
Although single PROMIS items are being developed for the 
remaining subdomains (ie, feeding, communication, and self-
care and grooming), the group chose to use well-established 
single items from existing stroke registers for these domains 
(Table). It is anticipated that there may be some degree of over-
lap between elements, which will be revised in future refine-
ments after feasibility and early user acceptance testing. It was 
Table.  Summary of Outcomes and Measures Included in the ICHOM Standard Set for Stroke
Measure Timing Data Source
Survival and disease control
  Survival All-cause mortality Discharge*, 90 days†,  
1–5 years‡
Administrative data
  Self-report of new stroke after admission After your hospitalization for stroke, have 
you been told by a doctor that you have 
had a new stroke?
90 days Clinical or patient-reported
  Adherence to smoking cessation advice After your hospitalization for stroke, have 
you smoked tobacco or cigarettes?
90 days Patient-reported
Acute complications
  Symptomatic ICH after thrombolysis Did the patient develop symptomatic ICH 
after treatment of ischemic stroke with 
thrombolysis?
Discharge Clinical
Patient-reported health status
  Cognitive and psychiatric functioning
   Global cognitive function PROMIS-10 90 days Patient-reported
   Mood PROMIS-10 90 days Patient-reported
  Motor functioning
   Mobility Are you able to ambulate?
PROMIS-10
Discharge, 90 days
90 days
Clinical or patient-reported
Patient-reported
   Self care and grooming Do you receive help from anybody to go 
to the toilet?
Do you receive help with dressing/
undressing?
Discharge, 90 days
Discharge, 90 days
Patient-reported
Patient-reported
   Feeding Do you need a tube for feeding? Discharge, 90 days Patient-reported
   Ability to return to usual activities Simplified modified Rankin Scale 
Questionnaire
(smRSq)
PROMIS-10
90 days
90 days
Clinical
Patient-reported
  Nonmotor functioning
   Pain and other unpleasant sensations PROMIS-10 90 days Patient-reported
   Fatigue PROMIS-10 90 days Patient-reported
  Social functioning
   Ability to communicate Do you have problems with 
communication or understanding?
Discharge, 90 days Patient-reported
   Social participation PROMIS-10 90 days Patient-reported
  General health status PROMIS-10 90 days Patient-reported
  Health-related quality of life PROMIS-10 90 days Patient-reported
ICH indicates intracerebral hemorrhage; and PROMIS-10, Patient Reported Outcomes Measurement Information System 10-Question Short Form 
(PROMIS SF v.1.1 Global Health; http://www.nihpromis.org).
*Discharge or 7 days after admission for index event (whichever occurs first).
†Ninety days after admission for index event within 30-day window (ie, 90–120 days after index admission).
‡Minimum of 1 year after index event with recommendation to track annually until 5 years after index event.
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decided to include overlap with established data collection 
efforts as well by including the mRS at the 90-day assessment. 
The mRS is commonly used and can be obtained with the sim-
plified mRS Questionnaire (smRSq), which is validated, easy 
to administer, translatable into multiple languages, and can be 
performed by raters with diverse professional experiences and 
skill levels with substantial reliability.22
Risk Adjustment Variables
The minimum set of risk adjustment variables that can be 
obtained in many countries included stroke type and severity 
(stroke type, stroke severity, and duration of symptoms); gen-
eral patient demographics (age, sex, race/ethnicity, prestroke 
functional status, whether living alone, and living location); 
vascular and systemic risk factors (prior stroke, prior TIA, prior 
myocardial infarction, coronary artery disease, atrial fibrilla-
tion, diabetes mellitus, hypertension, hyperlipidemia, smok-
ing status, and alcohol use); and treatment/care-related factors 
(diagnostic evaluation, length of stay, comfort care, rehabili-
tation, and discharge destination; Table III in the online-only 
Data Supplement). The risk factors selected reflect an empha-
sis on covariates that are most strongly associated with disease 
outcomes and are feasible for collection. The group favored a 
single set of measures and variables for both IS and ICH rather 
than a different set of variables for each disease for ease of use 
and for appropriateness in care settings, where IS and ICH can-
not be so easily distinguished because of the lack of neuroim-
aging. Most of these risk adjustment variables can be obtained 
by patient or proxy report with guidance from supporting 
clinical or administrative data (eg, history of diabetes melli-
tus, hypertension, or coronary artery disease). The Charlson 
Comorbidity Index can be estimated from administrative data 
for sites that have this capacity.23,24 Of note, the categories 
and specificity of race/ethnicity differ by country, as do the 
means to capture them, and their collection and reporting may 
also be constrained by regulation. Stroke subtype is obtained 
from clinical information and confirmed by imaging, with the 
understanding that certain resource limited settings may not 
have access to specialty care or diagnostic imaging studies. 
The NIH Stroke Scale (NIHSS) was considered the best option 
for assessment of stroke severity given its wide acceptance in 
global clinical practice.13 The group decided to focus on 3 sin-
gle patient–reported items (mobility, toileting, and dressing) to 
obtain a readily available and pragmatic measure of prestroke 
functional status because of the challenges inherent in the ret-
rospective use of more in-depth instruments. The risk adjust-
ment variables are collected at the time of hospital presentation 
for the index event. Despite the minimum set of risk adjust-
ment variables recommended, it is expected and encouraged 
that many sites will use the opportunity to begin or continue 
collecting additional data elements and measures, such as the 
use of anticoagulants before admission. It is expected that with 
implementation, additional candidate variables will be identi-
fied and included in future versions.
Data Collection
To compare data easily between providers, institutions, and 
populations requires data collection methods that minimize 
variation. For example, using the same sources of data can 
improve consistency regardless of the inherent differences 
that underlie the details of data collection. The recommended 
sources outlined in Table include patient- or proxy-reported 
sources, clinical data abstraction or provider report, and 
administrative data (eg, death registers or claims data). An 
international standard set also allows for opportunities to pilot 
inexpensive forms of digital data collection, such as auto-
mated smartphone surveys or remote follow-up visits using 
telehealth as opposed to the traditional and expensive method 
of in-person or dedicated phone-based assessments.25
For every measure, the group also recommended that the 
data source and the response rate of patient-reported mea-
sures be tracked. Although the Standard Set is amenable to 
be included as part of an existing register, the group recom-
mended that data could be tracked locally by centers and pro-
viders who do not have access to a national register or central 
data repository because of regulatory or technical challenges.
Discussion
Strengths of the Standard Set
An established set of standard data collection items creates an 
opportunity to increase patient value by improving the reliabil-
ity and consistency of data about the quality of stroke care.26 
Our aim acknowledges the challenges and certain uncertainty 
that confront patients during the acute and subacute stroke 
periods.27 Although randomized clinical trials are the mainstay 
of comparing outcomes between treatments, registers built 
into routine clinical practice are an incontrovertible comple-
ment in determining the degree to which a treatment or ser-
vice is safe, effective, patient-centered, timely, efficient, and 
equitable as outlined in the Institute of Medicine’s report on 
quality in healthcare.28 To ensure high rates of data complete-
ness, which is critical for valid comparisons across settings, 
the Standard Set favors simplicity and pragmatism of data col-
lection over complexity and highly detailed data specification. 
Functional outcome scales commonly used in clinical trials, 
such as the Barthel Index, Short Form-36, and Stroke Specific 
Quality of Life were not selected because many of their rel-
evant domains are covered adequately by the simplified, open-
access, and versatile PROMIS-10 platform.
Implementation
A complete data specification and collection manual is avail-
able on the ICHOM website (http://www.ichom.org/
medical-conditions/stroke), which describes each domain 
and subdomain, their definitions and corresponding measures, 
and their potential data sources. In the next phase of work, 
ICHOM and affiliated organizations will begin pilot collec-
tion, develop a standardized collection platform, and compare 
data quality and outcomes from the Standard Set in various 
settings.
Limitations
The utility of the Standard Set in practice is undetermined, and 
it is derived from expert consensus rather than high levels of 
evidence. To create a worldwide standard that could be applied 
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in both high- and low-income countries, many elements famil-
iar to registers in high-income countries are absent. There is 
limited ability to account for variability, including availability 
of mechanical thrombolysis, detailed ascertainment of stroke 
cause, and other treatment variations. Many items have been 
validated in single registers; however, the value of the Standard 
Set will only be discernable if it is implemented and field tested 
with rigorous evaluation criteria. This includes feasibility test-
ing with proxy responses for patients that are unable to respond 
for themselves, and determination of data elements that can 
better address the challenges in capturing information about 
cognitive impairment from self-assessments. If the Standard 
Set becomes adopted as an acceptable measure set, then there 
may be a prospective role for involving other larger scale 
stakeholders. The group also recognizes that to support greater 
transparency in quality of care for stroke patients, continued 
investments in register infrastructure and health information 
technology are required to overcome the financial and logis-
tical barriers in collecting and tracking this type of outcome 
data. Given the growing ubiquity of smartphones globally, data 
collection through simple, web-based, and mobile phone strat-
egies is a potential opportunity to increase feasibility.
There exist wide variations in stroke outcomes based 
on institutional and provider differences, suggesting sub-
stantial room for improvement in the implementation and 
development of global stroke services.29 The global adop-
tion of the Standard Set will assist healthcare providers and 
policy makers in their efforts to improve stroke systems of 
care and improve equitable access to care. This in turn creates 
powerful opportunities to inform and learn from each other 
through meaningful comparison of outcomes and facilitates 
the broader implementation of essential stroke services.
Conclusions
The stroke outcomes working group has defined a mini-
mum recommended set of consensus patient-centered out-
comes for collection in all adults with new stroke that can be 
implemented in a variety of healthcare settings. The use of 
the Standard Set will help inform healthcare providers in the 
delivery of effective, equitable, patient-centered, value-based 
stroke care worldwide.
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